- Home
- CRIS vs ZCMD Comparison
CRIS vs ZCMD Comparison
Compare CRIS & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- ZCMD
- Stock Information
- Founded
- CRIS 2000
- ZCMD 2012
- Country
- CRIS United States
- ZCMD China
- Employees
- CRIS N/A
- ZCMD N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- ZCMD Other Consumer Services
- Sector
- CRIS Health Care
- ZCMD Real Estate
- Exchange
- CRIS Nasdaq
- ZCMD Nasdaq
- Market Cap
- CRIS 21.3M
- ZCMD 29.0M
- IPO Year
- CRIS 2000
- ZCMD 2020
- Fundamental
- Price
- CRIS $1.81
- ZCMD $1.16
- Analyst Decision
- CRIS Strong Buy
- ZCMD
- Analyst Count
- CRIS 2
- ZCMD 0
- Target Price
- CRIS $16.50
- ZCMD N/A
- AVG Volume (30 Days)
- CRIS 163.8K
- ZCMD 597.6K
- Earning Date
- CRIS 07-31-2025
- ZCMD 01-01-0001
- Dividend Yield
- CRIS N/A
- ZCMD N/A
- EPS Growth
- CRIS N/A
- ZCMD N/A
- EPS
- CRIS N/A
- ZCMD N/A
- Revenue
- CRIS $11,202,000.00
- ZCMD $15,864,773.00
- Revenue This Year
- CRIS N/A
- ZCMD N/A
- Revenue Next Year
- CRIS $10.67
- ZCMD N/A
- P/E Ratio
- CRIS N/A
- ZCMD N/A
- Revenue Growth
- CRIS 14.17
- ZCMD N/A
- 52 Week Low
- CRIS $1.02
- ZCMD $0.95
- 52 Week High
- CRIS $8.29
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- CRIS 43.58
- ZCMD 46.90
- Support Level
- CRIS $1.50
- ZCMD $1.12
- Resistance Level
- CRIS $1.98
- ZCMD $1.24
- Average True Range (ATR)
- CRIS 0.19
- ZCMD 0.13
- MACD
- CRIS -0.05
- ZCMD -0.01
- Stochastic Oscillator
- CRIS 43.88
- ZCMD 16.03
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.